Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, März W, Pepys M B, Brenner H
Department of Internal Medicine II-Cardiology, University of Ulm Medical Center, Ulm, Germany.
Circulation. 1999 Dec 7;100(23):2326-31. doi: 10.1161/01.cir.100.23.2326.
There is controversy about the association between Helicobacter pylori infection and manifestations of coronary heart disease (CHD), the potential role of the more virulent H pylori strains, and whether or not a positive serostatus is related to increased levels of markers of systemic inflammation.
We assessed the prevalence of an infection with H pylori and in particular the anti-cytotoxin-associated protein A (CagA) antibody response of the more virulent strains expressing CagA in 312 patients with stable CHD and in 479 control subjects. Serological prevalence of H pylori infection (IgG titer) was significantly higher in patients than in control subjects after adjustment for age and sex (44.2% versus 31.3%, P<0.001). After adjustment for various covariates in multiple logistic regression, the odds ratio (OR) for CHD was 1.3 (95% CI, 0.9 to 1.9) given a positive IgG serostatus. The prevalence of CagA-positive strains was 27.9% in patients and 21.7% in control subjects (P=0.076 adjusted for age and sex). The OR for CHD in the fully adjusted model was 1.1 (95% CI, 0.7 to 1.7). None of the inflammatory markers (C-reactive protein, fibrinogen, plasma viscosity, or leukocytes) was significantly different according to serostatus.
In this large case-control study, the association of H pylori infection with stable CHD was strongly reduced and was no longer statistically significant after controlling for potential confounders. We also found no independent association between the more virulent strains and CHD. In addition, a positive serostatus was not associated with a systemic inflammatory response. Thus, these data do not support the hypothesis that infection with H pylori might be a major risk factor for stable CHD.
幽门螺杆菌感染与冠心病(CHD)表现之间的关联、毒性更强的幽门螺杆菌菌株的潜在作用以及血清学阳性状态是否与全身炎症标志物水平升高相关存在争议。
我们评估了312例稳定型冠心病患者和479例对照者中幽门螺杆菌感染的患病率,尤其是表达细胞毒素相关蛋白A(CagA)的毒性更强菌株的抗CagA抗体反应。在调整年龄和性别后,患者中幽门螺杆菌感染的血清学患病率(IgG滴度)显著高于对照者(44.2%对31.3%,P<0.001)。在多因素逻辑回归中调整各种协变量后,IgG血清学阳性状态下冠心病的比值比(OR)为1.3(95%CI,0.9至1.9)。患者中CagA阳性菌株的患病率为27.9%,对照者中为21.7%(调整年龄和性别后P=0.076)。在完全调整模型中,冠心病的OR为1.1(95%CI,0.7至1.7)。根据血清学状态,炎症标志物(C反应蛋白、纤维蛋白原、血浆粘度或白细胞)均无显著差异。
在这项大型病例对照研究中,幽门螺杆菌感染与稳定型冠心病之间的关联在控制潜在混杂因素后显著降低且不再具有统计学意义。我们还发现毒性更强的菌株与冠心病之间无独立关联。此外,血清学阳性状态与全身炎症反应无关。因此,这些数据不支持幽门螺杆菌感染可能是稳定型冠心病主要危险因素的假说。